Aclipse Therapeutics to Present ALS Development Program at Symposia
07 Nov 2024 //
BUSINESSWIRE
Aclipse Expands Drug Development Pipeline with Agreement with Chong Kun Dang
14 Sep 2023 //
BUSINESSWIRE
Aclipse Announces $2.2 Million Grant from UK’s Medical Research Council
26 Jan 2021 //
BUSINESSWIRE